Cargando…
Disease-modifying effects of ranibizumab for central retinal vein occlusion
PURPOSE: To identify anatomic endpoints altered by intravitreal ranibizumab in central retinal vein occlusion (CRVO) to determine any potential underlying disease modification that occurs with anti-vascular endothelial growth factor (anti-VEGF) therapy beyond best-corrected visual acuity and central...
Autores principales: | Huang, Jason M., Khurana, Rahul N., Ghanekar, Avanti, Wang, Pin-wen, Day, Bann-Mo, Blodi, Barbara A., Domalpally, Amitha, Quezada-Ruiz, Carlos, Ip, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850212/ https://www.ncbi.nlm.nih.gov/pubmed/34613454 http://dx.doi.org/10.1007/s00417-021-05224-x |
Ejemplares similares
-
Evaluation of non-exudative microcystoid macular abnormalities secondary to retinal vein occlusion
por: Francone, Anibal, et al.
Publicado: (2021) -
The usefulness of the retinal sensitivity measurement with a microperimetry for predicting the visual prognosis of branch retinal vein occlusion with macular edema
por: Fujino, Ryosuke, et al.
Publicado: (2020) -
Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
por: Kida, Teruyo, et al.
Publicado: (2021) -
Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion
por: Fortunato, Pina, et al.
Publicado: (2009) -
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)